Clinical trial
Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent…
NCT00136526 · University of Washington, Other · Completed
Key facts
| NCT number | NCT00136526 |
|---|---|
| Title | Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent Prostate Cancer |
| Official title | Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent Prostate Cancer: A Phase II Study |
| Lead sponsor | University of Washington, Other |
| Collaborators | Sanofi Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | Docetaxel and Diethylstilbestrol (DES) |
| Enrollment | 30 |
| Start date | Dec 1, 2002 |
| Completion | Oct 1, 2007 |
| First posted | Aug 29, 2005 |
| Last update posted | May 9, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: